Search Results - "Reynolds, Evan L"

The effect of surgical weight loss on diabetes complications in individuals with class II/III obesity by Reynolds, Evan L., Watanabe, Maya, Banerjee, Mousumi, Chant, Ericka, Villegas-Umana, Emily, Elafros, Melissa A., Gardner, Thomas W., Pop-Busui, Rodica, Pennathur, Subramaniam, Feldman, Eva L., Callaghan, Brian C.

“…Aims/hypothesis The aim of this study was to determine the effect of bariatric surgery on diabetes complications in individuals with class II/III obesity (BMI…”
Get full text

Quantification of high-specificity cyclic diguanylate signaling by Massie, Jonathan P, Reynolds, Evan L, Koestler, Benjamin J, Cong, Jian-Ping, Agostoni, Marco, Waters, Christopher M

“…Cyclic di-GMP (c-di-GMP) is a second messenger molecule that regulates the transition between sessile and motile lifestyles in bacteria. Bacteria often encode…”
Get full text

Diagnostic characteristics of nerve conduction study parameters for vasculitic neuropathy by Davalos, Long, Watanabe, Maya, Gallagher, Gary W., Grewal, Avneet, Fudym, Yelena, Reynolds, Evan L., Callaghan, Brian C., Banarjee, Mousumi, London, Zachary N.

“…Introduction/aims In vasculitic neuropathy (VN), a 50% side‐to‐side difference in the amplitude of compound muscle action potentials and sensory nerve action…”
Get full text

Neuropsychological Outcomes in Individuals With Type 1 and Type 2 Diabetes by Putnam, Nathaniel M, Reynolds, Evan L, Banerjee, Mousumi, Mizokami-Stout, Kara, Albright, Dana, Lee, Joyce, Pop-Busui, Rodica, Feldman, Eva L, Callaghan, Brian C

“…To determine the prevalence of neuropsychological outcomes in individuals with type 1 diabetes compared to individuals with type 2 diabetes or without…”
Get full text

Low Engagement of Advance Care Planning Among Patients Who Had a Stroke or Transient Ischemic Attack by Skolarus, Lesli E, Robles, Maria Cielito, Mansour, Maria, Sudore, Rebecca L, Reynolds, Evan L, Burke, James F, Corches, Casey L, Brown, Devin L

Get full text

Serum lipidomic determinants of human diabetic neuropathy in type 2 diabetes by Afshinnia, Farsad, Reynolds, Evan L., Rajendiran, Thekkelnaycke M., Soni, Tanu, Byun, Jaeman, Savelieff, Masha G., Looker, Helen C., Nelson, Robert G., Michailidis, George, Callaghan, Brian C., Pennathur, Subramaniam, Feldman, Eva L.

“…Objective The serum lipidomic profile associated with neuropathy in type 2 diabetes is not well understood. Obesity and dyslipidemia are known neuropathy risk…”
Get full text

Plasma lipid metabolites associate with diabetic polyneuropathy in a cohort with type 2 diabetes by Rumora, Amy E., Guo, Kai, Alakwaa, Fadhl M., Andersen, Signe T., Reynolds, Evan L., Jørgensen, Marit E., Witte, Daniel R., Tankisi, Hatice, Charles, Morten, Savelieff, Masha G., Callaghan, Brian C., Jensen, Troels S., Feldman, Eva L.

“…Objective The global rise in type 2 diabetes is associated with a concomitant increase in diabetic complications. Diabetic polyneuropathy is the most frequent…”
Get full text

The determinants of complication trajectories in American Indians with type 2 diabetes by Reynolds, Evan L, Akinci, Gulcin, Banerjee, Mousumi, Looker, Helen C, Patterson, Adam, Nelson, Robert G, Feldman, Eva L, Callaghan, Brian C

Get full text

Monoclonal antibody‐mediated immunosuppression enables long‐term survival of transplanted human neural stem cells in mouse brain by McGinley, Lisa M., Chen, Kevin S., Mason, Shayna N., Rigan, Diana M., Kwentus, Jacquelin F., Hayes, John M., Glass, Emily D., Reynolds, Evan L., Murphy, Geoffrey G., Feldman, Eva L.

“…Background As the field of stem cell therapy advances, it is important to develop reliable methods to overcome host immune responses in animal models. This…”
Get full text

Association between brain health outcomes and metabolic risk factors in persons with diabetes by Reynolds, Evan L, Votruba, Kristen, Jack, Clifford R, Beare, Richard, Reid, Robert I, Preboske, Gregory M, Waseta, Camille, Pop-Busui, Rodica, Nelson, Robert G, Callaghan, Brian C, Feldman, Eva L

“…We performed a cross-sectional study to determine associations between cognition and MRI-derived brain outcomes, with obesity, diabetes duration, and metabolic…”
Get full text

The determinants of complication trajectories in American Indians with type 2 diabetes by Reynolds, Evan L, Akinci, Gulcin, Banerjee, Mousumi, Looker, Helen C, Patterson, Adam, Nelson, Robert G, Feldman, Eva L, Callaghan, Brian C

“…BACKGROUNDWe aimed to determine whether metabolic syndrome (MetS) affects longitudinal trajectories of diabetic complications, including neuropathy,…”
Get full text

Intravenous immunoglobulin and plasma exchange prescribing patterns for Guillain‐Barre Syndrome in the United States—2001 to 2018 by Stino, Amro M., Reynolds, Evan L., Watanabe, Maya, Callaghan, Brian C.

“…Introduction/Aims Randomized controlled trials show that repeat intravenous immunoglobulin (IVIG) dosing and plasma exchange (PLEX) followed by IVIG…”
Get full text

Possible sex and racial disparities in myasthenia gravis care by Suresh, Shriya, Watanabe, Maya, Reynolds, Evan L., Callaghan, Brian C.

“…Introduction/Aims Given the importance of early diagnosis and treatment of myasthenia gravis (MG), it is critical to understand disparities in MG care. We…”
Get full text

Costs and Utilization of New-to-Market Neurologic Medications by Reynolds, Evan L., Gallagher, Gary, Hill, Chloe E., Banerjee, Mousumi, Mante, Aristotle, Esper, Gregory J., Callaghan, Brian C.

“…The objective of this study was to compare the utilization and costs (total and out-of-pocket) of new-to-market neurologic medications with existing…”
Get full text

Costs Are Still on the Rise for Commonly Prescribed Branded Neurologic Medications by Gusovsky, Amanda V, Lin, Chun Chieh, Kerber, Kevin, Reynolds, Evan L, Callaghan, Brian C, Burke, James F

“…To observe medication cost trends for 5 common neurologic conditions. We quantified annual out-of-pocket (OOP) and total medication costs for patients seen by…”
Get full text

Bidirectional Associations Between Mental Health Disorders and Chronic Diabetic Complications in Individuals With Type 1 or Type 2 Diabetes by Watanabe, Maya, Reynolds, Evan L, Banerjee, Mousumi, Charles, Morten, Mizokami-Stout, Kara, Albright, Dana, Ang, Lynn, Lee, Joyce M, Pop-Busui, Rodica, Feldman, Eva L, Callaghan, Brian C

“…To determine bidirectional associations between the timing of chronic diabetes complications (CDCs) and mental health disorders (MHDs) in individuals with type…”
Get full text

1158-P: The Effect of Surgical Weight Loss on Diabetic Complications in the Severely Obese by REYNOLDS, EVAN L., WATANABE, MAYA, ELAFROS, MELISSA, FELDMAN, EVA L., CALLAGHAN, BRIAN C.

“…The aim of this study was to determine the effect of surgical weight loss on chronic kidney disease (CKD) , retinopathy, and cardiovascular autonomic…”
Get full text

Randomized controlled trial of a clinical decision support system for painful polyneuropathy by Reynolds, Evan L., Burke, James F., Banerjee, Mousumi, Callaghan, Brian C.

“…Introduction Despite the existence of guidelines, painful neuropathy is often inappropriately treated. We sought to determine the effectiveness of a clinical…”
Get full text

1340-P: Complications 30 Years from Diagnosis amongst Participants in the Cognition and Longitudinal Assessment of Risk Factors over 30 Years (CLARiFY) Study by BROWN, AMY, REYNOLDS, EVAN L., GBADEYAN, OYETUNDE, MORAN, CHRIS, SAKOWSKI, STACEY A., SRIKANTH, VELANDAI, NORTHAM, ELISABETH A., CAMERON, FERGUS, BEARE, RICHARD, FELDMAN, EVA L.

“…There are few longitudinal cohort studies in type 1 diabetes that originate in the immediate post-DCCT era. We recruited participants who had initially…”
Get full text

1010-P: Cost and Utilization of Health Care Services for Persons with Diabetes by REYNOLDS, EVAN L., MIZOKAMI-STOUT, KARA R., PUTNAM, NATHANIEL, BANERJEE, MOUSUMI, ALBRIGHT, DANA, LEE, JOYCE M., BUSUI, RODICA, FELDMAN, EVA L., CALLAGHAN, BRIAN C.

“…Objective: To describe and compare healthcare costs and utilization for persons with type 1 diabetes (T1D), type 2 diabetes (T2D), and those without diabetes…”
Get full text